Fosamprenavir
Lexiva, Telzir (fosamprenavir) is a small molecule pharmaceutical. Fosamprenavir was first approved as Lexiva on 2003-10-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
| Trade Name | Telzir |
|---|---|
| Common Name | Fosamprenavir |
| Indication | acquired immunodeficiency syndrome, hiv infections |
| Drug Class | Antivirals: HIV protease inhibitors (saquinavir type); phosphoro-derivatives |
